National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Immune Dysregulation and Pathobiology Working Group Report

Juan Gea-Banacloche, Krishna V. Komanduri, Paul Carpenter, Sophie Paczesny, Stefanie Sarantopoulos, Jo Anne Young, Nahed El Kassar, Robert Q. Le, Kirk R. Schultz, Linda M. Griffith, Bipin N. Savani, John R. Wingard

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Immune reconstitution after hematopoietic stem cell transplantation (HCT) beyond 1 year is not completely understood. Many transplant recipients who are free of graft-versus-host disease (GVHD) and not receiving any immunosuppression more than 1 year after transplantation seem to be able to mount appropriate immune responses to common pathogens and respond adequately to immunizations. However, 2 large registry studies over the last 2 decades seem to indicate that infection is a significant cause of late mortality in some patients, even in the absence of concomitant GVHD. Research on this topic is particularly challenging for several reasons. First, there are not enough long-term follow-up clinics able to measure even basic immune parameters late after HCT. Second, the correlation between laboratory measurements of immune function and infections is not well known. Third, accurate documentation of infectious episodes is notoriously difficult. Finally, it is unclear what measures can be implemented to improve the immune response in a clinically relevant way. A combination of long-term multicenter prospective studies that collect detailed infectious data and store samples as well as a national or multinational registry of clinically significant infections (eg, vaccine-preventable severe infections, opportunistic infections) could begin to address our knowledge gaps. Obtaining samples for laboratory evaluation of the immune system should be both calendar and eventdriven. Attention to detail and standardization of practices regarding prophylaxis, diagnosis, and definitions of infections would be of paramount importance to obtain clean reliable data. Laboratory studies should specifically address the neogenesis, maturation, and exhaustion of the adaptive immune system and, in particular, how these are influenced by persistent alloreactivity, inflammation, and viral infection. Ideally, some of these long-term prospective studies would collect information on long-term changes in the gut microbiome and their influence on immunity. Regarding enhancement of immune function, prospective measurement of the response to vaccines late after HCT in a variety of clinical settings should be undertaken to better understand the benefits as well as the limitations of immunizations. The role of intravenous immunoglobulin is still not well defined, and studies to address it should be encouraged.

Original languageEnglish (US)
JournalBiology of Blood and Marrow Transplantation
DOIs
StateAccepted/In press - Oct 5 2016

Fingerprint

Cell Transplantation
National Institutes of Health (U.S.)
Hematopoietic Stem Cell Transplantation
Infection
Graft vs Host Disease
Registries
Immune System
Immunization
Vaccines
Prospective Studies
Intravenous Immunoglobulins
Opportunistic Infections
Virus Diseases
Documentation
Immunosuppression
Multicenter Studies
Immunity
Transplantation
Inflammation
Mortality

Keywords

  • Immune reconstitution
  • Immunization
  • Intravenous immunoglobulin
  • Late infections

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this

National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative : The Immune Dysregulation and Pathobiology Working Group Report. / Gea-Banacloche, Juan; Komanduri, Krishna V.; Carpenter, Paul; Paczesny, Sophie; Sarantopoulos, Stefanie; Young, Jo Anne; El Kassar, Nahed; Le, Robert Q.; Schultz, Kirk R.; Griffith, Linda M.; Savani, Bipin N.; Wingard, John R.

In: Biology of Blood and Marrow Transplantation, 05.10.2016.

Research output: Contribution to journalArticle

Gea-Banacloche, Juan ; Komanduri, Krishna V. ; Carpenter, Paul ; Paczesny, Sophie ; Sarantopoulos, Stefanie ; Young, Jo Anne ; El Kassar, Nahed ; Le, Robert Q. ; Schultz, Kirk R. ; Griffith, Linda M. ; Savani, Bipin N. ; Wingard, John R. / National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative : The Immune Dysregulation and Pathobiology Working Group Report. In: Biology of Blood and Marrow Transplantation. 2016.
@article{8c6f2812727f4affb7e7a32c364ea60d,
title = "National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Immune Dysregulation and Pathobiology Working Group Report",
abstract = "Immune reconstitution after hematopoietic stem cell transplantation (HCT) beyond 1 year is not completely understood. Many transplant recipients who are free of graft-versus-host disease (GVHD) and not receiving any immunosuppression more than 1 year after transplantation seem to be able to mount appropriate immune responses to common pathogens and respond adequately to immunizations. However, 2 large registry studies over the last 2 decades seem to indicate that infection is a significant cause of late mortality in some patients, even in the absence of concomitant GVHD. Research on this topic is particularly challenging for several reasons. First, there are not enough long-term follow-up clinics able to measure even basic immune parameters late after HCT. Second, the correlation between laboratory measurements of immune function and infections is not well known. Third, accurate documentation of infectious episodes is notoriously difficult. Finally, it is unclear what measures can be implemented to improve the immune response in a clinically relevant way. A combination of long-term multicenter prospective studies that collect detailed infectious data and store samples as well as a national or multinational registry of clinically significant infections (eg, vaccine-preventable severe infections, opportunistic infections) could begin to address our knowledge gaps. Obtaining samples for laboratory evaluation of the immune system should be both calendar and eventdriven. Attention to detail and standardization of practices regarding prophylaxis, diagnosis, and definitions of infections would be of paramount importance to obtain clean reliable data. Laboratory studies should specifically address the neogenesis, maturation, and exhaustion of the adaptive immune system and, in particular, how these are influenced by persistent alloreactivity, inflammation, and viral infection. Ideally, some of these long-term prospective studies would collect information on long-term changes in the gut microbiome and their influence on immunity. Regarding enhancement of immune function, prospective measurement of the response to vaccines late after HCT in a variety of clinical settings should be undertaken to better understand the benefits as well as the limitations of immunizations. The role of intravenous immunoglobulin is still not well defined, and studies to address it should be encouraged.",
keywords = "Immune reconstitution, Immunization, Intravenous immunoglobulin, Late infections",
author = "Juan Gea-Banacloche and Komanduri, {Krishna V.} and Paul Carpenter and Sophie Paczesny and Stefanie Sarantopoulos and Young, {Jo Anne} and {El Kassar}, Nahed and Le, {Robert Q.} and Schultz, {Kirk R.} and Griffith, {Linda M.} and Savani, {Bipin N.} and Wingard, {John R.}",
year = "2016",
month = "10",
day = "5",
doi = "10.1016/j.bbmt.2016.10.001",
language = "English (US)",
journal = "Biology of Blood and Marrow Transplantation",
issn = "1083-8791",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative

T2 - The Immune Dysregulation and Pathobiology Working Group Report

AU - Gea-Banacloche, Juan

AU - Komanduri, Krishna V.

AU - Carpenter, Paul

AU - Paczesny, Sophie

AU - Sarantopoulos, Stefanie

AU - Young, Jo Anne

AU - El Kassar, Nahed

AU - Le, Robert Q.

AU - Schultz, Kirk R.

AU - Griffith, Linda M.

AU - Savani, Bipin N.

AU - Wingard, John R.

PY - 2016/10/5

Y1 - 2016/10/5

N2 - Immune reconstitution after hematopoietic stem cell transplantation (HCT) beyond 1 year is not completely understood. Many transplant recipients who are free of graft-versus-host disease (GVHD) and not receiving any immunosuppression more than 1 year after transplantation seem to be able to mount appropriate immune responses to common pathogens and respond adequately to immunizations. However, 2 large registry studies over the last 2 decades seem to indicate that infection is a significant cause of late mortality in some patients, even in the absence of concomitant GVHD. Research on this topic is particularly challenging for several reasons. First, there are not enough long-term follow-up clinics able to measure even basic immune parameters late after HCT. Second, the correlation between laboratory measurements of immune function and infections is not well known. Third, accurate documentation of infectious episodes is notoriously difficult. Finally, it is unclear what measures can be implemented to improve the immune response in a clinically relevant way. A combination of long-term multicenter prospective studies that collect detailed infectious data and store samples as well as a national or multinational registry of clinically significant infections (eg, vaccine-preventable severe infections, opportunistic infections) could begin to address our knowledge gaps. Obtaining samples for laboratory evaluation of the immune system should be both calendar and eventdriven. Attention to detail and standardization of practices regarding prophylaxis, diagnosis, and definitions of infections would be of paramount importance to obtain clean reliable data. Laboratory studies should specifically address the neogenesis, maturation, and exhaustion of the adaptive immune system and, in particular, how these are influenced by persistent alloreactivity, inflammation, and viral infection. Ideally, some of these long-term prospective studies would collect information on long-term changes in the gut microbiome and their influence on immunity. Regarding enhancement of immune function, prospective measurement of the response to vaccines late after HCT in a variety of clinical settings should be undertaken to better understand the benefits as well as the limitations of immunizations. The role of intravenous immunoglobulin is still not well defined, and studies to address it should be encouraged.

AB - Immune reconstitution after hematopoietic stem cell transplantation (HCT) beyond 1 year is not completely understood. Many transplant recipients who are free of graft-versus-host disease (GVHD) and not receiving any immunosuppression more than 1 year after transplantation seem to be able to mount appropriate immune responses to common pathogens and respond adequately to immunizations. However, 2 large registry studies over the last 2 decades seem to indicate that infection is a significant cause of late mortality in some patients, even in the absence of concomitant GVHD. Research on this topic is particularly challenging for several reasons. First, there are not enough long-term follow-up clinics able to measure even basic immune parameters late after HCT. Second, the correlation between laboratory measurements of immune function and infections is not well known. Third, accurate documentation of infectious episodes is notoriously difficult. Finally, it is unclear what measures can be implemented to improve the immune response in a clinically relevant way. A combination of long-term multicenter prospective studies that collect detailed infectious data and store samples as well as a national or multinational registry of clinically significant infections (eg, vaccine-preventable severe infections, opportunistic infections) could begin to address our knowledge gaps. Obtaining samples for laboratory evaluation of the immune system should be both calendar and eventdriven. Attention to detail and standardization of practices regarding prophylaxis, diagnosis, and definitions of infections would be of paramount importance to obtain clean reliable data. Laboratory studies should specifically address the neogenesis, maturation, and exhaustion of the adaptive immune system and, in particular, how these are influenced by persistent alloreactivity, inflammation, and viral infection. Ideally, some of these long-term prospective studies would collect information on long-term changes in the gut microbiome and their influence on immunity. Regarding enhancement of immune function, prospective measurement of the response to vaccines late after HCT in a variety of clinical settings should be undertaken to better understand the benefits as well as the limitations of immunizations. The role of intravenous immunoglobulin is still not well defined, and studies to address it should be encouraged.

KW - Immune reconstitution

KW - Immunization

KW - Intravenous immunoglobulin

KW - Late infections

UR - http://www.scopus.com/inward/record.url?scp=85006976678&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85006976678&partnerID=8YFLogxK

U2 - 10.1016/j.bbmt.2016.10.001

DO - 10.1016/j.bbmt.2016.10.001

M3 - Article

C2 - 27751936

AN - SCOPUS:85006976678

JO - Biology of Blood and Marrow Transplantation

JF - Biology of Blood and Marrow Transplantation

SN - 1083-8791

ER -